• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem.

作者信息

Fanaroff Alexander C, Wang Tracy Y

机构信息

Penn Cardiovascular Outcomes, Quality and Evaluative Research Center, Leonard Davis Institute, and Cardiovascular Medicine Division, University of Pennsylvania, Philadelphia (A.C.F.).

Division of Cardiovascular Medicine and Duke Clinical Research Institute, Duke University, Durham, NC (T.Y.W.).

出版信息

Circ Cardiovasc Interv. 2022 Jul;15(7):e012262. doi: 10.1161/CIRCINTERVENTIONS.122.012262. Epub 2022 Jul 19.

DOI:10.1161/CIRCINTERVENTIONS.122.012262
PMID:35861801
Abstract
摘要

相似文献

1
Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem.经皮冠状动脉介入治疗中的风险预测：解决最后一公里问题。
Circ Cardiovasc Interv. 2022 Jul;15(7):e012262. doi: 10.1161/CIRCINTERVENTIONS.122.012262. Epub 2022 Jul 19.
2
Clinical characteristics and in-hospital outcome in percutaneous coronary interventions with ST elevation myocardial infarction patients developing acute kidney injury.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗并发急性肾损伤的临床特征及院内结局
J Pak Med Assoc. 2019 Dec;69(12):1827-1833. doi: 10.5455/JPMA.23481.
3
Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时的急性肾损伤定义及院内死亡率
J Am Heart Assoc. 2016 Jul 6;5(7):e003522. doi: 10.1161/JAHA.116.003522.
4
Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.在接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的患者中，桡动脉与股动脉入路与对比剂诱导的急性肾损伤的相关性。
Cardiovasc Revasc Med. 2016 Dec;17(8):546-551. doi: 10.1016/j.carrev.2016.07.008. Epub 2016 Jul 21.
5
The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction.评估TIMI风险指数对ST段抬高型心肌梗死患者造影剂所致急性肾损伤的预测价值。
Acta Cardiol. 2020 Feb;75(1):77-84. doi: 10.1080/00015385.2018.1551263. Epub 2019 Jan 25.
6
Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者对比剂诱导的急性肾损伤和死亡率。
Heart. 2018 May;104(9):767-772. doi: 10.1136/heartjnl-2017-311975. Epub 2017 Nov 1.
7
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.血清尿酸升高是行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者对比剂相关急性肾损伤的预测因子。
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2140-2143. doi: 10.1016/j.numecd.2021.04.002. Epub 2021 Apr 19.
8
Renal Dysfunction and Outcomes in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的肾功能不全与预后
Am J Cardiol. 2024 Apr 15;217:35-38. doi: 10.1016/j.amjcard.2024.01.039. Epub 2024 Feb 24.
9
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.ST段抬高型心肌梗死患者药物介入策略与直接经皮冠状动脉介入治疗的倾向评分匹配分析
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003508.
10
Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.评估中性粒细胞明胶酶相关载脂蛋白和胱抑素 C 作为经皮冠状动脉介入治疗 ST 段抬高型心肌梗死后急性肾损伤的生物标志物。
Arch Cardiovasc Dis. 2019 Mar;112(3):180-186. doi: 10.1016/j.acvd.2018.11.006. Epub 2019 Jan 9.

引用本文的文献

1
Automated Real-Time Percutaneous Coronary Intervention Risk Model Leveraging Electronic Health Records.利用电子健康记录的自动实时经皮冠状动脉介入治疗风险模型
JACC Adv. 2025 Jun 25;4(7):101865. doi: 10.1016/j.jacadv.2025.101865.
2
Machine learning approaches for risk prediction after percutaneous coronary intervention: a systematic review and meta-analysis.经皮冠状动脉介入治疗后风险预测的机器学习方法：系统评价与荟萃分析
Eur Heart J Digit Health. 2024 Oct 14;6(1):23-44. doi: 10.1093/ehjdh/ztae074. eCollection 2025 Jan.
3
Contemporary Risk Models for In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention.
当代经皮冠状动脉介入治疗后住院和 30 天死亡率风险模型。
Curr Cardiol Rep. 2024 May;26(5):451-457. doi: 10.1007/s11886-024-02047-0. Epub 2024 Apr 9.
4
A Geriatric Approach to Percutaneous Coronary Interventions in Older Adults, Part II: A Expert Panel.老年患者经皮冠状动脉介入治疗的老年医学方法，第二部分：专家小组
JACC Adv. 2023 Jul;2(5). doi: 10.1016/j.jacadv.2023.100421. Epub 2023 Jul 28.